Following her debut column as author of ESMO Perspectives’ On target, Elena Garralda, Principal Investigator of our Early Clinical Drug Development Group, and Director of VHIO’s Research Unit for Molecular Therapy of Cancer (UITM) – CaixaResearch, now discusses the importance of achieving a deeper understanding of tumor cell dormancy.
Drawing on recently published research*, Elena highlights the need to manipulate this potential therapeutic window for preventing cancer cell spread. To read Elena’s second On Target column and access this month’s ESMO Perspectives, please visit: https://perspectives.esmo.org/. To sign up/opt in to automatically receive all future editions as well as other ESMO newsletters click here.
###
*Correia AL, Guimaraes JC, Auf der Maur P, De Silva D, Trefny MP, Okamoto R, Bruno S, Schmidt A, Mertz K, Volkmann K, Terracciano L, Zippelius A, Vetter M, Kurzeder C, Weber WP, Bentires-Alj M. Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy. Nature. 2021 Jun;594(7864):566-571.
